Medication noncompliance in patients with chronic disease: Issues in dialysis and renal transplantation

American Journal of Managed Care

Volumn 9, Issue 2, 2003, Pages 155-171

  Loghman Adham, Mahmoud ^a,b  

^a HOFFMANN LA ROCHE INC   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; IMMUNOSUPPRESSIVE AGENT; ORAL ANTIDIABETIC AGENT; PHOSPHATE BINDING AGENT; PREDNISONE; URINARY TRACT AGENT; VITAMIN D DERIVATIVE;

AGE; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ASTHMA; CANCER; CHRONIC DISEASE; CLINICAL TRIAL; CORRELATION ANALYSIS; DEPRESSION; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIALYSIS; DIET RESTRICTION; DOCTOR PATIENT RELATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG COST; DRUG HALF LIFE; DRUG MONITORING; DRUG URINE LEVEL; FACE EDEMA; FAMILY; GRAFT FAILURE; GRAFT REJECTION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEART DISEASE; HEMODIALYSIS; HIRSUTISM; HOME DIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; INHALER; IRON THERAPY; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LONG TERM CARE; META ANALYSIS; MOTIVATION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PERITONEAL DIALYSIS; PERITONITIS; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RACE DIFFERENCE; REVIEW; SECONDARY HYPERPARATHYROIDISM; SOCIAL ASPECT; SOCIOECONOMICS; TREATMENT OUTCOME;

DRUG COSTS; DRUG MONITORING; HEALTH BEHAVIOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RENAL DIALYSIS; SELF ADMINISTRATION; SOCIAL SUPPORT; TREATMENT REFUSAL;

EID: 0037291454     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (152)

1. Haynes RB, Taylor DW, Sacklett DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979: 145-156.
2. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: Patient complicance, devices, and inhalation technique. Chest. 2000;117:542-550.
3. Mullen PD. Compliance becomes concordance [editorial]. BMJ. 1997;314:691.
4. Hanson RW. Physician-patient communication and compliance. In: Gerner KE, Nehemkis AM, eds. Compliance: The Dilemma of the Chronically Ill. New York, NY: Springer Publishing Co; 1986:182-212.
5. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs. 1995;49:321-327.
6. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
7. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications [published correction appears in Lancet 1997;349:1180]. Lancet. 1996;348:383-386.
8. Horowitz RI, Horowitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993; 153:1863-1868.
9. Murphy J, Coster G. Issues in patient compliance. Drugs. 1997;54:797-800.
10. Cramer JA. Feedback on mediation dosing enhances patient compliance. Chest. 1993;104:333-334.
11. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med. 1990;150:1377-1378.
12. Melnikow J, Kiefe C. Patient compliance and medical research: Issues in methodology. J Gen Intern Med. 1994;9:96-105.
13. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer. 1993;71:3441-3449.
14. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2001 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Am J Kidney Dis. 2001(suppl 3);38:v-viii.
15. Economic cost of ESRD. Am J Kidney Dis. 2001;38(suppl 3):S181-S194.
16. Kshirsagar AV, Hogan SL, Mandelkehr L, Falk RJ. Length of stay and costs for hospitalized hemodialysis patients: Nephrologists versus internists. J Am Soc Nephrol. 2000;11:1526-1533.
17. Anonymous. 1999 Annual Report of the US Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data 1989-1998. January 2003. Rockville, MD and Richmond VA: HHS/HRSA/OSP/OSP/DOT and UNOS. Available at: www.optn.org/latest/Data/rptData.asp. Accessed January 17, 2003.
18. Anonymous. Précis: A summary of the United States ESRD Program. Am J Kidney Dis. 2001;38(suppl 3):S17-S36.
19. Dusing R, Weisser B, Mengden T, Vetter H. Changes in anti-hypertensive therapy: The role of adverse effects of compliance. Blood Press. 1998;7:313-315.
20. Evans L, Spelman M. The problem of non-compliance with drug therapy. Drugs. 1983;25:63-76.
21. Curtins RB, Svarstad BL, Keller TH. Hemodialysis patients' noncompliance with oral medications. ANNA J. 1999;26:307-316.
22. Kaplan B, Mason NA, Shimp LA, Ascione FJ. Chronic hemodialysis patients, part I: Characterization and drug-related problems. Ann Pharmacother. 1994;28:316-319.
23. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: Predictors and survival analysis. Am J Kidney Dis. 1998;32:139-145.
24. Kimmel PL, Peterson RA, Weihs KL, et al. Behavioral compliance with hemodialysis prescription in hemodialysis patients. J Am Soc Nephrol. 1995;5:1826-1834.
25. Bame SI, Petersen N, Wry BP. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med. 1993;37:1035-1043.
26. Blackburn S. Dietary compliance of chronic hemodialysis patients. J Am Diet Assoc. 1977;70:31-37.
27. Safdar N, Baakza H, Kumar H, Naqvi SA. Non-compliance to diet and fluid restrictions in haemodialysis patients. J Pak Med Assoc. 1995;45:293-295.
28. Clearly DJ, Matzke GR, Alexander ACM, Joy MS. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm. 1995;52:1895-1900.
29. Mai FM, Busby K, Bell RC. Clinical rating of compliance in chronic hemodialysis patients. Can J Psychiatry 1999;44:478-482.
30. Korbin SM, Kimmel PL, Simmens SJ, Reiss D. Behavioral and biochemical indices of compliance in hemodialysis patients. ASAIO Trans. 1991;37:M378-M380.
31. Morduchowicz G, Sulkes J, Aizic S, Gabbay U, Winkler J, Boner G. Compliance in hemodialysis patients: A multivariate regression analysis. Nephron. 1993;64:365-368.
32. Ramos EL, Kasiske BL, Alexander SR, et al. The evaluation of candidates for renal transplantation: The current practice of US transplant centers. Transplantation. 1994;57:490-497.
33. Brownbridge G, Fielding DM. Psychological adjustment and adherence to dialysis treatment regimens. Pediatr Nephrol. 1994;8:744-749.
34. Hoover H. Compliance in hemodialysis patients: A review of the literature. J Am Diet Assoc. 1989;89:957-959.
35. Bernardini J, Piraino B. Compliance in CAPD and CCPD patients as measured by supply inventories during home visits. Am J Kidney Dis. 1998;31:101-107.
36. Everett KD, Sletten C, Carmack C, Brantley PJ, Jones GN, McKnight GT. Predicting non-compliance to fluid restriction in hemodialysis patients. Dial Transplant. 1993;22:614-622.
37. Held PJ, Port FK, Wolf RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550-556.
38. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis. 1998;31:607-617.
39. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis. 2000;35:1226-1237.
40. Tong EM, Nissenson R. Erythropoietin and anemia. Semin Nephrol. 2001:21:190-203.
41. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis. 1996;28:53-61.
42. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease, 2000. Am J Kidney Dis. 2001;37(suppl):S182-S238.
43. Nicoletta P, Bernardini J, Dacko C, Terry C, Fried L. Compliance with subcutaneous erythropoietin in peritoneal dialysis patients. Adv Perit Dial. 2000;16:90-92.
44. Bleyer AJ, Hylander B, Sudo H, et al. An international study of patient compliance with hemodialysis. JAMA 1999;281:1211-1213.
45. Scarr S. Individuality and community: The contrasting role of the state in family life in the United States and Sweden. Scand J Psychol. 1996;37:93-102.
46. Diaz-Buxo JA, Plahey K, Walker S. Memory card: A tool to assess patient compliance with peritoneal dialysis. Artif Organs. 1999;23:956-958.
47. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277.
48. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: An evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17:126-132.
49. Rovelli M, Palmeri D, Vossler E, Bartus S, Hull D, Schweizer R. Non-compliance in organ transplant recipients. Transplant Proc. 1989;21:833-834.
50. Didlake RH, Dreyfus K, Kerman RH, Van Buren CT, Kahan BD. Patient non-compliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc. 1988;20:63-69.
51. DeGeest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation. 1995;59:340-347.
52. Hilbrands LB, Hoitsma AJ, Koene RAP. Medication compliance after renal transplantation. Transplantation. 1995;60:914-920.
53. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation. 1993;55:51-56.
54. Greenstein S, Siegal B. Compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplantation. 1998;66:1718-1726.
55. Beck DE, Fennell RS, Yost RL, Robinson JD, Geary D, Richards GA. Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants. J Pediatr. 1980;96:1094-1097.
56. Hong JH, Sumrani N, Delaney V, Davis R, Dibenedetto A, Butt KM. Causes of late renal allograft failure in the cyclosporine era. Nephron. 1992;62:272-279.
57. Dunn J, Golden D, Van Buren CT, Lewis RM, Lawen J, Kahan BD. Causes of graft loss beyond two years in the cyclosporine era. Transplantation. 1990;49:349-353.
58. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation. 1990;49:374-377.
59. Douglas S, Blixen C, Bartucci MR. Relationship between pretransplant noncompliance and posttransplant outcomes in renal transplant recipients. J Transplant Coord. 1996;6:53-58.
60. Meyers KE, Weiland H, Thomson PD. Pediatric renal transplantation non-compliance. Pediatr Nephrol. 1995;9:189-192.
61. Morgenstern BZ, Murphy M, Dayton J, et al. Noncompliance in a pediatric renal treatment population. Transplant Proc. 1994;26:129.
62. Wolff G, Strecker K, Vester U, Latta K, Ehrich JH. Non-compliance following renal transplantation in children and adolescents. Pediatr Nephrol. 1998;12:703-708.
63. Blowey DL, Hébert D, Arbus GS, Pool R, Korus M, Koren G. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol. 1997;11:547-551.
64. Greestein S, Siegal B. Odds probabilities of compliance and noncompliance in patients with a functioning renal transplant: A multicenter study. Transplant Proc. 1999;31:280-281.
65. Sketris I, Waite N, Grobler K, West M, Gerus S. Factors affecting compliance with cyclosporine in adult renal transplant patients. Transplant Proc. 1994;26:2538-2541.
66. Siegal BR, Greenstein SM. Post renal transplant compliance from the perspective of African-Americans, Hispanic Americans, and Anglo-Americans. Adv Ren Replace Ther. 1997;4:46-54.
67. Swanson MA, Palmeri D, Vossler ED, Bartus SA, Hull D, Schweizer RT. Noncompliance in organ transplant recipients. Pharmacotherapy. 1991;11:173S-174S.
68. Raiz LR, Kitty KM, Henry M, Ferguson RM. Medication compliance following renal transplantation. Transplantation. 1999;68:51-55.
69. Frazier PM, Davis-Ali, Dahl KE. Correlates of noncompliance among renal transplant recipients. Clin Transplant. 1994;8:550-557.
70. Tagliacozzo D, Ima K. Knowledge of illness as a predictor of patient behavior. J Chronic Dis. 1970;22:765-775.
71. O'Brien ME. Hemodialysis regimen compliance and social environment: A panel analysis. Nurs Res. 1980;29:250-255.
72. Kalil RS, Heim-Duthoy KL, Kasiske BL. Patients with a low income have a reduced renal allograft survival. Am J Kidney Dis. 1992;20:63-69.
73. Takemoto S, Terasaki PI. A comparison of kidney transplant survival in white and black recipients. Transplant Proc. 1989;21:3865-3868.
74. Meyers KEC. Noncompliance in children and adolescents after renal transplantation. Transplantation. 1996;62:186-189.
75. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000;70:1240-1244.
76. Greenstein S, Siegal B. Evaluation of a multivariate model predicting noncompliance with medication regimen among renal transplant patients. Transplantation. 2000;69:2226-2228.
77. Bunzel B, Laederach-Hofmann K. Solid organ transplantation: Are three predictors for postransplant noncompliance? A literature overview. Transplantation. 2000;70:711-716.
78. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21:1074-1090.
79. Cummings KM, Kirscht JP, Becker MH, Levin NW. Construct validity of three methods for measuring patient compliance. Health Serv Res. 1984;19:103-116.
80. Waterhouse DM, Calzone KA, Mele C, Brenner DE. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol. 1993;11:1189-1197.
81. Meredith PA, Torgerson DJ. Electronic approaches should be more widely used. BMJ. 1998;316:393-394.
82. Paes AH, Bkker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci. 1998;20:73-77.
83. Puller T, Kumar S, Tindall H, Feely M. Time to stop counting tablets? Clin Pharmacol Ther. 1989;461:163-168.
84. Rudd P, Byny RL, Zachary V, et al. Pill count measures of compliance in a drug trial: Variability and suitability. Am J Hypertens. 1988;1:309-312.
85. Rudd P, Ahmed S, Zachary V, Barton C, Bonduelle D. Issues in patient compliance: The search for therapeutic sufficiency. Cardiology. 1992;80(Suppl 1):2-10.
86. Dunbar J. Adherence measures and their utility. Control Clin Trials. 1984;5:515-521.
87. Blackwell B. The drug regimen and treatment compliance. In: Haynes RB, Taylor DW, Sacket DL, eds. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press; 1979:145-156.
88. Rudd P. Partial compliance: Implications for clinical practice. J Cardiovasc Pharmacol. 1993;22(suppl A)S1-S5.
89. Eisen SA, Hanpeter JA, Kreuger LW, Gard M. Monitoring medication compliance: Description of a new device. J Compliance Health Care 1987;2:131-142.
90. Averbuch M, Weintraub M, Pollack DJ. Compliance assessment in clinical trials: The MEMS device. J Clin Res Pharmacoepidemiol. 1990;4:199-204.
91. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J Respir Crit Care Med. 1994;149:S69-S76.
92. Coutts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medications in asthma. Arch Dis Child. 1991;67:332-333.
93. Cramer JA, Schleyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-1510.
94. Fujii J, Sekin A. Compliance and compliance-improving strategies in hypertension: The Japanese experience. J Hypertens Suppl. 1998;3:S19-S22.
95. Raynor DK, Booth TG, Blankinsopp A. Effect of computer generated reminder charts on patient compliance with drug regimens. BMJ. 1993;306:1158-1161.
96. Stevens-Simon C, O'Connor P, Bassford K. Incentives enhance postpartum compliance among adolescent prenatal patients. J Adolesc Health. 1994;15:393-399.
97. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315:703-707.
98. Morris LS, Schullz RM. Patient compliance: An overview. J Clin Pharm Ther. 1992;17:283-295.
99. Morris LS, Schultz RM. Medication compliance: The patient's perspective. Clin Ther. 1993;15:593-606.
100. Cramer JA. Identifying and improving compliance patterns: A composite plan for health care providers. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven press; 1991:387-392.
101. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000;160:2101-2109.
102. Lau RC, Matsui D, Greenberg M, Koren G. Electronic measurement of compliance with mercaptopurine in pediatric patients with acute lymphoblastic leukemia. Med Pediatr Oncol. 1998;30:85-90.
103. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31-37.
104. Caro JJ, Salas M, Speckman JL, Raggio G, Jackson JD. Effect of initial drug choice on persistence with antihypertensive therapy: The importance of actual practice data. CMAJ. 1999;160:41-46.
105. Dew MA, Roth LH, Thompson ME, Kormos RL, Griffith BP. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15:631-645.
106. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is the patient taking the treatment as prescribed? JAMA. 1993;269:2779-2781.
107. Wannamaker BB, Morton WA, Gross AJ, Saunders S. Improvement in antiepileptic drug levels following reduction of interval between clinic visits. Epilepsia. 1980;21:155-162.
108. Larrat EP, Taubman AH, Willey C. Compliance-related problems in the ambulatory population. Am Pharm. 1990;NS30:18-23.
109. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Pryzbeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-1884.
110. Pullar T, Birtwell AJ, Wiles PG, Hay A, Feely MP. Use of a pharmacologic indicator to compare compliance with tables prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther. 1988;44:540-545.
111. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997;20:1512-1517.
112. Kruse W, Eggert-Kruse W, Rampmaier J, Runnebaum B, Weber E. Dosage frequency and drug compliance behaviour: A comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol. 1991;41:589-592.
113. Logan AG. Role of paraprofessionals in improving compliance with antihypertensive treatment. J Hypertens Suppl. 1985;3(1):S65-S68.
114. Becker MH, Mainman LA, Kirscht JP, Haefner DP, Drachman RH. The health belief model and prediction of dietary compliance. J Health Soc Behav. 1977;18:348-366.
115. Janz NK, Becker MH. The health belief model: A decade later. Health Educ Q. 1984;11:1-47.
116. Parker K, Howell MH, Healy KE, et al. Nursing intervention based on the health belief model and compliance in patients on chronic analysis. J Nephrol Nurs. 1985;2:144-151.
117. Wiebe JS, Christensen AJ. Health beliefs, personality, and adherence in hemodialysis patients: An interactional perspective. Ann Behav Med. 1997;19:30-35.
118. Blackburn SL. Dietary compliance of chronic hemodialysis patients. J Am Diet Assoc. 1977;70:31-37.
119. Wenerowicz WJ, Riskind JH, Jenkins PG. Locus of control and degree of compliance in hemodialysis patients. J Dial. 1978;2:495-505.
120. Poll IB, De-Nour AK. Locus of control and adjustment to chronic haemodialysis. Psychol Med. 1980;10:153-157.
121. Zetin M, Plummer MJ, Vaziri ND, Cramer M. Locus of control and adjustment to chronic hemodialysis. Clin Exp Dial Apharesis. 1981;5:319-334.
122. Lin CC, Liang CC. The relationship between health locus of control and compliance of hemodialysis patients. Kaohsiung J Med Sci. 1997;13:243-254.
123. Sensky T, Leger C, Gilmour S. Psychological and cognitive factors associated with adherence to dietary and fluid restriction regimens by people on chronic haemodialysis. Psychother Psychosom. 1996;65:36-42.
124. Willey C, Redding C, Stafford J, et al. Stagesh of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clin Ther. 2000;22:858-871.
125. Shaw-Stuart NJ, Stuart A. The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis. J Ren Nutr. 2000;10:80-84.
126. Christensen AJ, Smith TW. Personality and patient adherence: Correlates of the five-factor model in renal dialysis. J Behav Med. 1995;18:305-313.
127. Wong BS, Norman DC. Evaluation of a novel medication aid, the calendar blister pack, and its effect on drug compliance in a geriatric outpatient clinic. J Am Geriatr Soc. 1987;35:219-226.
128. Becker MH, Maiman LA. Strategies for enhancing patient compliance. J Community Health. 1980;6:113-135.
129. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 1991;48:1978-1988.
130. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, eds. Patient Compliance in Medical Practice and Clinical Trials. New York, NY: Raven Press; 1991:3-10.
131. Urquhart J. Patient non-compliance with drug regimens: Measurement, clinical correlates, and economic impact. Eur Heart J. 1996;17(suppl A):8-15.
132. Cramer JA. Enhancing patient compliance in the elderly: Role of packaging aids and monitoring. Drugs Aging. 1998;12:7-15.
133. Huang HY, Maguire MG, Miller ER III, Appel LJ. Impact of pill organizers, and blister packs on adherence to pill taking in two vitamin supplementation trials. Am J Epidemiol. 2000;15:780-787.
134. Sbarbaro JA. Strategies to improve compliance with therapy. Am J Med. 1985;20:34-37.
135. Bittar N. Maintaining long-term control of blood pressure: The role of improved compliance. Clin Cardiol. 1995;18(suppl 3):12-16.
136. Peck CL, King NJ. Increasing patient compliance with prescriptions. JAMA. 1982;248:2874-2878.
137. Cummings KM, Becker MH, Kirscht JP, Levin NW. Intervention strategies to improve compliance with medical regimens by ambulatory hemodialysis patients. J Behav Med. 1981;4:111-127.
138. Nicolucci A, Cavaliere D, Scorpiglione N, et al. A comprehensive assessment of the availability of long-term complications of diabetes: A case-control study. Diabetes Care. 1996;19:927-933.
139. Devine E. Meta-analysis of the effects of psychoeducational care in adults with asthma. Res Nurs Health. 1996;19:367-376.
140. Shapiro RS, Deshetler N, Stockard HE. Fluid overload again! A technique to enhance fluid compliance. Dialysis Transplant. 1994;23:303-305, 334.
141. Schlatter S, Ferrans CE. Teaching program effects on high phosphorus levels in patients receiving hemodialysis. Anna J. 1998;25:31-36.
142. Golper T. Patient education: Can it maximize the success of therapy? Nephrol Dial Transplant. 2001;16(suppl 7):20-24.
143. Cegala DJ, Martinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9:57-64.
144. Brody DA. The patient's role in clinical decision making. Ann Intern Med. 1980;93:718-722.
145. Elixhauser A, Eisen SA, Romeis JC, Homan SM. The effects of monitoring and feedback on compliance. Med Care. 1990;28:882-893.
146. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest. 1993;104:501-507.
147. Rand CS, Wise RA, Nides M, et al. Metered-dose inhaler adherence in a clinical trial. Am Rev Repir Dis. 1992;146:1559-1564.
148. Kaveh K, Kimmel PL. Compliance in hemodialysis patients: Multidimensional measures in search of a gold standard. Am J Kidney Dis. 2001;37:244-266.
149. McKenney JM. Methods of modifying compliance behavior in hypertensive patients. Drug Intell Clin Pharm. 1981;15:8-14.
150. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of intervensions to improve compliance: A meta-analysis. Med Care. 1998;36:1138-1161.
151. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research: A comprehensive review. J Clin Pharm Ther. 2001;26:331-342.
152. Keshaviah P, Collins AJ, Ma JZ, Churchill DN, Thorpe KE. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy. J Am Soc Nephrol. 2002;13(suppl 1):S48-S52.